Clinical Trials Directory

Trials / Completed

CompletedNCT00598377

Adrenal Functions in Autosomal Dominant Polycystic Kidney Disease

Assessment of Adrenal Functions in Patients With Autosomal Dominant Polycystic Kidney Disease

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
49 (actual)
Sponsor
Istanbul University · Academic / Other
Sex
All
Age
20 Years – 56 Years
Healthy volunteers
Accepted

Summary

We aimed to evaluate the hypothalamus-pituitary-adrenal axis in autosomal dominant polycystic kidney disease (ADPKD) patients. Twenty two ADPKD patients and 27 healthy subjects were enrolled.

Detailed description

CONTEXT: Autosomal dominant polycystic kidney disease (ADPKD) is the most common hereditary kidney disease and extrarenal manifestations may be observed in many organ systems. Hypothalamus-pituitary-adrenal axis in patients with ADPKD was not evaluated extensively. OBJECTIVE: We aimed to evaluate the hypothalamus-pituitary-adrenal axis in ADPKD patients. METHODS: Twenty two ADPKD patients and 27 healthy subjects were enrolled. Basal dehydroepiandrosterone-sulfate (DHEAS) levels and cortisol and dehydroepiandrosterone responses to low dose short adrenocorticotropin stimulation test were assessed. Correlation analyses of these parameters with glomerular filtration rates, renal volumes and pain characteristics in patients with ADPKD were done.

Conditions

Interventions

TypeNameDescription
DRUGTetracosactin1 microgram tetracosactin, intravenous injection, once for the test

Timeline

Start date
2006-09-01
Primary completion
2007-09-01
Completion
2007-09-01
First posted
2008-01-21
Last updated
2009-02-19

Locations

1 site across 1 country: Turkey (Türkiye)

Source: ClinicalTrials.gov record NCT00598377. Inclusion in this directory is not an endorsement.